Everforth Inc quarterly report, Q2 FY2004

Business Context and Reporting Period

Company: On Assignment, Inc. (Note: Input metadata listed "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2004
Business Overview: A leading provider of skilled temporary professionals to clients in the science and healthcare industries. The company operates two segments: Healthcare Staffing (Nurse Travel and Medical Financial/Allied) and Lab Support (scientific staffing for biotech, pharma, etc.).

Key Financial Metrics

Metric Three Months Ended
June 30, 2004
Six Months Ended
June 30, 2004
Revenues $46,313,000 $92,739,000
Gross Profit $12,025,000 $23,838,000
Gross Margin 26.0% 25.7%
Operating Loss $(4,883,000) $(7,419,000)
Net Loss $(2,990,000) $(4,493,000)
Loss Per Share (Basic/Diluted) $(0.12) $(0.18)
Cash and Cash Equivalents $31,072,000 (Balance Sheet) N/A
Working Capital $48,554,000 N/A
Total Debt $0 (No long-term debt reported) N/A

Material Changes vs. Prior Period

  • Revenue Decline: Revenues decreased 14.5% year-over-year for the quarter and 17.2% for the six-month period. This was driven by a reduction in the average number of temporary professionals on assignment (down 17.4% in Healthcare and 18.6% in Lab Support) due to increased competition and economic slowdowns in R&D spending.
  • Operating Loss Improvement: While the company reported an operating loss of $4.9M for the quarter, this is a significant improvement compared to the $79.5M operating loss in the same period in 2003. The 2003 loss was heavily impacted by a one-time non-cash goodwill impairment charge of $79.9M.
  • Expense Increases: Selling, general, and administrative (SG&A) expenses increased 14.4% year-over-year for the quarter. This was primarily due to increased field operating expenses and corporate costs associated with the company's "revitalization plan," including hiring and marketing.
  • Cash Flow: Net cash used for operating activities was $364,000 for the six months ended June 30, 2004, compared to cash provided by operations of $1.5M in the prior year period. Cash and cash equivalents decreased by $4.1M during the period.

Guidance, Outlook, and Risks

  • Outlook: Management does not expect to generate net income for the remaining quarters of 2004 due to the timing of resource investments associated with the revitalization plan. The focus for the remainder of 2004 is on revenue and gross profit growth; 2005 will focus on optimizing income generation by streamlining the organization.
  • Revitalization Plan: The company is executing a plan approved in February 2004 to strengthen the management team and field force. Significant progress has been made in hiring, and the company expects branch and corporate operating expenses to remain relatively flat sequentially for the rest of 2004.
  • Capital Expenditures: The company expects to incur an additional $2M to $3M in capital expenditures over the next six months related to PeopleSoft implementation, IT projects, and leasehold improvements.
  • Risks: Key risks include actual demand for services, the timing of benefits from the revitalization plan, ability to attract/retain consultants, and competition. The company is also subject to seasonality, with reduced demand typically occurring during holiday periods and summer months.

Investor Verification Checklist

  • Revenue Stabilization: Verify if the sequential revenue increases noted in the Medical Financial and Lab Support segments continue in Q3 and Q4.
  • Revitalization ROI: Monitor the timeline for the "revitalization plan" investments to translate into profitability, as management explicitly forecasts continued net losses for the remainder of 2004.
  • Goodwill Impairment: Confirm that no further goodwill impairment charges are necessary, given the remaining balance of $43.5M and the company's history of impairment testing.
  • Cash Burn Rate: Track the cash balance ($31.1M) against the projected capital expenditures ($2M-$3M) and operating cash flow usage to ensure liquidity remains sufficient without a new borrowing facility.
  • Segment Mix: Analyze the shift in product mix toward "all-inclusive" billing in the Nurse Travel line, which management noted negatively impacted bill rates.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.